Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0% New York, United States , April 16, 2024 (GLOBE NEWSWIRE) -- The Global Testosterone Replacement Therapy Market Size is to grow from USD 1.98 Billion in 2023 to USD 2.93 Billion by 2033, at a...

Testosterone Replacement Therapy (TRT) Market to Hit US$ 2,556.13 Mn By 2030, Consegic Business Intelligence New York, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Consegic Business Intelligence analyzes Testosterone Replacement Therapy (TRT) Market is expected to witness significant growth at a remarkable CAGR of...

Global Continuous Renal Replacement Therapy Market Size To Hit USD 2.7 Billion By 2030 | CAGR of 8.91% New York, United States , March 14, 2023 (GLOBE NEWSWIRE) -- The Global Continuous Renal Replacement Therapy Market Size to grow from USD 1.3 billion in 2021 to USD 2.7 billion by 2030, at a...

Hormone Replacement Therapy Market Is Set to Expand at a CAGR Of 5.7% To reach US$ 27.8 Billion By The Year 2032: FMI Companies Profiled in Hormone Replacement Therapy Market are Eli Lilly and Company, Pfizer, Inc., AbbVie, Inc., Novo Nordisk A/S, Merck KGaA, Mylan N.V., Bayer Healthcare, F. Hoffmann-La Roche Ltd.,...